Lineage Cell Therapeutics Inc (STU:BT3)
€ 0.88 -0.042 (-4.54%) Market Cap: 224.05 Mil Enterprise Value: 181.35 Mil PE Ratio: 0 PB Ratio: 4.27 GF Score: 65/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1